Bing Zhu
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 16
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 6
- Pancreatic and Hepatic Oncology Research 4
-
- Multiple Sclerosis Research Studies 14
-
- Inhalation and Respiratory Drug Delivery 9
-
- RNA modifications and cancer 4
-
- Rheumatoid Arthritis Research and Therapies 4
-
- Bladder and Urothelial Cancer Treatments 4
- Co-authors
- Xiaoqi LinRobert S. HodgesNian ZhouBrian D. SykesSong‐Lin HuangHong‐Hao ZhouGiorgio InghiramiDaniela Traini
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (1 paper)Blood (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Bing Zhu
95 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 136
- Pharmacology 412
- Oncology 421
- Endocrinology, Diabetes and Metabolism 247
- Pathology and Forensic Medicine 245
- Complementary and alternative medicine 109
Countries citing papers authored by Bing Zhu
This map shows the geographic impact of Bing Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Zhu more than expected).
Fields of papers citing papers by Bing Zhu
This network shows the impact of papers produced by Bing Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Zhu. The network helps show where Bing Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bing Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 38 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 16 | |
| 7 | 2020 | 33 | |
| 8 | 2019 | 15 | |
| 9 | 2019 | 22 | |
| 10 | 2019 | 4 | |
| 11 | 2017 | 3 | |
| 12 | 2017 | 26 | |
| 13 | 2016 | 38 | |
| 14 | 2015 | 17 | |
| 15 | 2015 | 2 | |
| 16 | 2014 | 7 | |
| 17 | 2010 | 1 | |
| 18 | 2003 | 10 | |
| 19 | 2003 | 63 | |
| 20 | 2002 | 6 |
About Bing Zhu
Bing Zhu is a scholar working on Pharmacology, Microbiology and Pathology and Forensic Medicine, having authored 100 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Multiple Sclerosis Research Studies (14 papers), Inhalation and Respiratory Drug Delivery (9 papers), Drug Transport and Resistance Mechanisms (6 papers), Pancreatic and Hepatic Oncology Research (4 papers), RNA modifications and cancer (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Pharmacology (412 citations), Oncology (421 citations) and Endocrinology, Diabetes and Metabolism (247 citations). Bing Zhu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Xiaoqi Lin, Robert S. Hodges, Nian Zhou, Brian D. Sykes, Song‐Lin Huang, Hong‐Hao Zhou, Giorgio Inghirami, Daniela Traini, Paul M. Young and Jan F. Silverman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.